Skip to content

CareDx CDNA Lease Liability Payments - Due Year Two

Lease Liability Payments - Due Year Two at other companies

Veracyte logo
VeracyteVCYT
$7.17M-14.5%
Abbott logo
AbbottABT
$254M+0.8%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$362K
Natera, Inc. logo
Natera, Inc.NTRA
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$1.4B-9.6%
Enterprise value$1.35B-9.7%
P/S3.4×-1.1×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's lease liability payments - due year two.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CareDx's lease liability payments - due year two?
CareDx (CDNA) reported lease liability payments - due year two of $7.54M in Q1 2026.
How has CareDx's lease liability payments - due year two changed year-over-year?
CareDx's lease liability payments - due year two decreased by 7.7% year-over-year, from $8.17M to $7.54M.
What does lease liability payments - due year two mean?
This metric identifies the total cash payments required for operating and finance leases in the second year following the current balance sheet date. It helps investors forecast long-term fixed cost commitments and cash flow requirements. It is essential for modeling the company's future solvency and operational leverage.